glp 1 and sarcopenia GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenic Obesity | Current Nutrition Reports Novel Insights into the Roles

Some patients benefit from combination therapy or sequential medication trials to find optimal regimens

Current trends and challenges in cancer management and therapy using designer nanomaterials

Sensitivity analyses We conducted prespecified sensitivity analyses to evaluate the robustness of the target trial emulation and to probe key threats to validity, including residual confounding, reverse causation (protopathic bias), and time-related biases

Getting the math right means achieving maximum benefit per dollar spent

[PubMed] [Google Scholar] 25.Emerging pharmacotherapies for obesity: a systematic review [Online ahead of print] Kokkorakis M, Chakhtoura M, Rhayem C, Al Rifai J, Ghezzawi M, Valenzuela-Vallejo L, Mantzoros CS